Could Psychedelics Become Tripless?
Short Wave
The Quest for Non-Hallucinogenic Psychedelics
This chapter explores the development of non-hallucinogenic psychedelic drugs designed for therapeutic use, highlighting their potential benefits in treating conditions like depression. It features discussions on ongoing clinical trials, particularly focusing on the promising drug DLX1, while addressing the broader implications and debates within this emerging field.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
